|
Market Closed -
Nasdaq
01:00:00 07/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 234.76 USD | +3.27% |
|
+8.70% | +38.09% |
| 11-03 | RBC Raises Price Target on Jazz Pharmaceuticals to $305 From $296, Keeps Outperform Rating | MT |
| 11-03 | Jazz Pharmaceuticals plc, Q3 2026 Earnings Call, Nov 02, 2026 |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| JAZZ | Delayed | |
CBOE
| JAZZ | Real-time | |
Tradegate
| J7Z | Real-time | |
Deutsche Boerse AG
| J7Z | Delayed | |
Boerse Muenchen
| J7Z | Real-time | |
Börse Stuttgart
| J7Z | Delayed | |
Berne S.E.
| J7Z | End-of-day quote | |
Borsa Italiana
| 1JAZZ | End-of-day quote | |
Xetra
| J7Z | Delayed | |
Sao Paulo
| J2AZ34 | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Bullish |
| Resistance | 236.04 | 236.04 | 256.56 |
| Spread/Res. | -0.54% | -0.54% | -8.50% |
| Spread/Supp. | +14.48% | +14.48% | +15.41% |
| Support | 205.06 | 205.06 | 203.42 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- JAZZ Stock
- Charts Jazz Pharmaceuticals plc
Select your edition
All financial news and data tailored to specific country editions

















